The top 100 stock
market authors
selected for publication
market authors
selected for publication
rlwinvestor
»
Comments
» Single Comment
| 
Comments by Ticker
ACTC,
ADLS.OB,
ALXN,
ANR,
APPA,
APPY,
ARIA,
ARNA,
ASTM,
ATHX,
BHRT,
BTIM,
C,
CBAI,
CBAI.OB,
CCEL.OB,
CELG,
CRA,
CRXX,
CTIC,
CUR,
CYTX,
DDSS,
DNDN,
DYAX,
GERN,
GETA.OB,
GS,
HEB,
HGSI,
HOGS,
IART,
ILE,
IVGN,
JAV,
KOOL,
MBLTY.PK,
MEE,
MS,
MT,
NBS,
NEP,
NEPH.OB,
NKOFF.PK,
NRIFF.PK,
OPXA,
OREX,
OSTE,
PSTI,
RTIX,
7 comments
Rating: 1
(2 
-
1 is 
)
-
1 is )
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
-
This list is a little too broad. Really there are are only 3 companies that "directly" benefit from the ban: GERN, ACT.PK, and BTIM. The actual benefits are discussed with more depth in the latest post on tradingstemcells2009.b... .
Mar 12 09:35 am
|Rating:
+1
0
All Comments by rlwinvestor »Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]